TScan Therapeutics, Inc. Common Stock (TCRX) News

Latest headlines that mention TCRX, newest first · each headline opens the original publisher

TCRX quote

Last price: $0.19
Day change: -6.64%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

TCRX headlines

latest coverage

Investing.com 1mo ago

H.C. Wainwright downgrades Tscan stock rating on restructuring

General T3TCRX

Seeking Alpha News 1mo ago

TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study - Slideshow

General T2TCRX

Seeking Alpha News 1mo ago

TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study Transcript

General T2TCRX

Investing.com 1mo ago

Why is TScan Therapeutics stock collapsing today?

General T3TCRX

Yahoo Finance 1mo ago

TScan Therapeutics Cuts Workforce by 75% and Shifts Focus to Solid Tumor Program

General T2TCRX

Investing.com 2mo ago

Tscan Therapeutics earnings beat by $0.03, revenue fell short of estimates

Earnings T3TCRX

Investing.com 3mo ago

TScan Therapeutics at H.C. Wainwright: phase iii push gains pace

General T3TCRX

Yahoo Finance 4mo ago

TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss

General T2TCRX

Seeking Alpha 5mo ago

TScan Therapeutics GAAP EPS of -$0.22 misses by $0.01, revenue of $1M misses by $1.5M

Earnings T2TCRX

TCRX news alerts

Get an alert by email or push when a new headline mentions TCRX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.